UroToday20h
SUO 2024: Debate – Management of Localized Radiorecurrent Prostate Cancer: Salvage Radiotherapy
(UroToday.com) The 2024 SUO annual meeting included a prostate cancer session, featuring a debate regarding the management of ...
UroToday1d
SUO 2024: Risk Stratification AI-Driven Digital Biomarkers
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Prostate Cancer Session I. Dr. Okyaz Eminaga ...
UroToday2d
SUO 2024: Novel Approaches to Radiotherapy to Reduce Patient Burden
(UroToday.com) The 2024 SUO annual meeting included a health services session, featuring a presentation by Dr. Ann Raldow discussing novel approaches to radiotherapy to reduce patient burden. Frequent ...
UroToday2d
SUO 2024: Sexual Satisfaction Despite Sexual Dysfunction
(UroToday.com) The 2024 SUO annual meeting included a prostate cancer session, featuring a presentation by Dr. Daniela Wittmann discussing sexual satisfaction despite sexual dysfunction. Dr. Wittmann ...
UroToday2d
SUO 2024: Telehealth and Cancer: Public Policy and Future Directions
(UroToday.com) The 2024 SUO annual meeting included a health services session, featuring a presentation by Dr. Juan Andino discussing public policy and future directions of telehealth and cancer. The ...
UroToday2d
SUO 2024: Prostate Cancer Screening with Biomarkers and MRI–A European Perspective
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the European Association of Urology (EAU) Lecture. Dr.
UroToday2d
SUO 2024: A Phase III Study of 177Lu-TLX591 plus Standard-of-Care Versus Standard-of-Care Alone in Patients with mCRPC (PROSTACT GLOBAL)
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, TX between December 3 rd – 6 th, 2024 was host to a prostate cancer poster session. Dr. A. Oliver Sartor ...
UroToday3d
ESMO 2021 – Final Overall Survival Analysis From ARCHES, Results of Expanded Cohort 6 of the COSMIC-021 Study and Highlights in Prostate Cancer
Neeraj Agarwal presented results of the COSMIC-021 cohort 6, examining the role of cabozantinib and atezolizumab in patients with metastatic castration-resistant prostate cancer (mCRPC). Dr. Agarwal ...
UroToday5d
SUO 2024: Joseph A Smith, Jr. Mentorship Award Lecture
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Joseph A Smith, Jr. Mentorship Award Lecture. by Dr.
UroToday5d
SUO 2024: Biomarkers and Clinical Predictors in RCC
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Kidney Cancer Session II. Dr Mark Ball discussed ...
UroToday5d
SUO 2024: Update on Neoadjuvant Therapy Trials in RCC
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, ...